WHO ICTRP trial
Trace element loss in the regional citrate anticoagulation in continous renal…
ChiCTR-IPR-16010163 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR-IPR-16010163 |
|---|---|
| Public title | Trace element loss in the regional citrate anticoagulation in continous renal replacement therapy |
| Scientific title | Trace element loss in the regional citrate anticoagulation in continous renal replacement therapy |
| Primary sponsor | The First Affiliated Hospital of Nanjing Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | Pilot study |
| Countries | China |
| Conditions | Acute kidney injury,chronic kidney disease |
| Interventions | 1:Heparin anticoagulation;2:Regional citrate anticoagulation |
| Registration date | Dec 15, 2016 |
| Target size | 1:20;2:40 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: